NR4A1 and breast carcinoma: Organoids retained the expression of hormone receptors, including HER2 receptors; the analysis of genetic alterations, including gene mutations, copy number alterations, and gene expression profile, showed that breast cancer organoids displayed the typical heterogeneous genetic landscape of breast cancer and represent all of the breast cancer subtypes [484].